Higher serum B2M is well-known to be associated with higher mortality and rapid declines in kidney function among the general population [9, 10], non-dialyzed CKD patients [11] and patients on hemodialysis (HD) [12]. The gene discussed is B2M; the disease is chronic kidney disease.